Member Info for Bk2011

As a shareholder, I agree with you but as a consumer, I want to pay the lowest price. Opti website sells the same products at a much higher price than the same products on Amazon.

Https://amzn.eu/d/1dnUS0H

Amazon have a Prime day sale on the Cholbiome X3 and a few other slimbiome products if anyone is interested.

11.75p. Slightly different share price

Well that bounce was short lived

Certainly a few buys today with some good size trades.

Https://www.linkedin.com/posts/seedhealth_multi-species-synbiotic-supplementation-enhances-activity-7378438632401182721-Eg9Q?utm_source=share&utm_medium=member_android&rcm=ACoAAAK2LqYBuwHWPCKGkLCVqOB1ZJroyTfrpXg

Https://www.mdpi.com/2072-6643/17/17/2734

OptiBiotix Health plc announced that its Chief Executive, Stephen O’Hara, has purchased additional ordinary shares in the company, increasing his stake to 10.08%. This transaction, disclosed under UK Market Abuse Regulation, signifies confidence in the company’s strategic direction and may positively influence investor sentiment.

So it was SOH taking the gamble

Almost 500k shares bought so far today. Decent size gamble

We are at the point where confidence in the management and company is at an all time low with every positive news announcement being sold in to by the long suffering investors who were awaiting the imminent launch of sweetbiotix since Q1 last year.

Sweetbiotix is the only reason I still hold but seems like the can is constantly being kicked down the road. Gla.

Atleast they didn't leave the results announcement until the last minute.

Where are all the promised director buys?

This statement in the results statement is not true -

"The existing partnership with Seed delivered substantial growth, supported by Seed's ongoing success with existing products and aggressive expansion into new distribution channels."

Sales to Seed Health dropped by 60k compared to H1 last year.

Https://www.linkedin.com/posts/arome-science_microbiome-metabolomics-guthealth-activity-7368402683172507648-1CB-?utm_source=share&utm_medium=member_android&rcm=ACoAAAK2LqYBuwHWPCKGkLCVqOB1ZJroyTfrpXg

New study

https://www.mdpi.com/2072-6643/17/17/2734

Martinu - slimbiome is still only a small fish in the USA. Not selling in any huge volume. Way off $1m in revenue.

Unless there are other big deals not mentioned yet

Anyone care to share any insights or reasoning behind the listing on OTCQB?